Elevated liver transaminases, human immune deficiency virus (HIV) seroconversion and rapid progression to AIDS in a HIV prevention clinical trial participant: A case report
This is a case report on a human immune deficiency virus (HIV) prevention trial participant who HIV seroconverted, developed hepatitis and rapidly progressed to acquired immunodeficiency syndrome (AIDS). A 24 year old HIV negative, non-pregnant participant consented to participate in the FEM-PrEP clinical trial. Her baseline parameters were normal; she was on oral contraception and was vaccinated for hepatitis B. She...
Determinants of adherence to antiretroviral therapy (ART) among patients attending public and private health facilities in Nairobi, Kenya
For maximum suppression of the multiplication of the human immunodeficiency virus (HIV) virus and subsequent increase in the CD4 cell count, a level of adherence of 95% and above is required among the patients on Antiretroviral drugs (ARVs). Most patients on antiretroviral therapy (ART) in Nairobi are not achieving the optimum adherence level required to maintain treatment efficacy, hence the risk of drug...
Human immunodeficiency virus (HIV) positive females in Saudi Arabia: Pregnancy and neonatal outcome
This study was aimed to describe the demographic, presentation, clinical manifestation, and outcome of human immunodeficiency virus (HIV) positive females in Saudi Arabia. Special attention was drawn to the outcome of HIV positive pregnant females. A retrospective cohort study was conducted to evaluate HIV positive patients who presented to the emergency room and out-patient department in King Abdulaziz University...
Short-term combined exercise training improves the health of HIV-infected patients
This study tested the benefits of combined aerobic and resistance exercise training (CARET) in HIV-infected individuals receiving antiretroviral therapy. Twenty-three human immunodeficiency virus (HIV)-infected men and women, predominantly of lower socioeconomic status (SES), were randomly assigned and completed 12 weeks of: (a) standard medical treatment plus CARET or (b) standard medical treatment only. At baseline...
Hepatitis A vaccination among human immuno- deficiency virus (HIV)-infected adults: Current evidence and unanswered questions
Hepatitis A virus (HAV) infection is common, can cause significant morbidity and mortality, and the prevalence may be higher in populations infected or at risk for human immunodeficiency virus (HIV). Immunization with HAV vaccine is recommended for HIV-infected individuals, particularly men who have sex with men, injection drug users, hemophiliacs, those with chronic liver disease, and international travelers without...